Zyflamend induces apoptosis in pancreatic cancer cells via modulation of the JNK pathway

BACKGROUND: Current pharmacological therapies and treatments targeting pancreatic neuroendocrine tumors (PNETs) have proven ineffective, far too often. Therefore, there is an urgent need for alternative therapeutic approaches. Zyflamend, a combination of anti-inflammatory herbal extracts, that has p...

Descripción completa

Detalles Bibliográficos
Autores principales: Puckett, Dexter L., Alquraishi, Mohammed, Alani, Dina, Chahed, Samah, Donohoe, Dallas, Voy, Brynn, Whelan, Jay, Bettaieb, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427957/
https://www.ncbi.nlm.nih.gov/pubmed/32795297
http://dx.doi.org/10.1186/s12964-020-00609-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427957/
https://www.ncbi.nlm.nih.gov/pubmed/32795297
http://dx.doi.org/10.1186/s12964-020-00609-7

Ejemplares similares